Neri Paola, Tokoro Shunji, Yokoyama Shin-Ichiro, Miura Tsuyoshi, Murata Takeomi, Nishida Yoshihiro, Kajimoto Tetsuya, Tsujino Satoshi, Inazu Toshiyuki, Usui Taiichi, Mori Hiroshi
Laboratory of Microbiology, Department of Public Health Pharmacy, Gifu Pharmaceutical University, Gifu 502-8585, Japan.
Biol Pharm Bull. 2007 Sep;30(9):1697-701. doi: 10.1248/bpb.30.1697.
Shiga toxin (Stx) exerts toxic activity by binding to glycosphingolipids, mainly globotriaosyl (Gb(3)) ceramide, on the surface of target cells. The inhibition of toxin-receptor binding is a promising therapeutic approach to prevent Stx-mediated diseases. In this study, we synthesized monovalent Stx-ligands of phosphatidylethanolamine dipalmitoyl-Gb(3) (Gb(3)-PEDP) and galabiosyl (Gb(2))-PEDP and we examined their neutralizing activity against Stx-1 and Stx-2 in vitro. Both Gb(3)-PEDP and Gb(2)-PEDP strongly neutralized the cytotoxicity of Stx-1 and Stx-2. It is likely that the mechanism of neutralization involved formation of liposomes and consequently clustering of sugar units. We propose monovalent Gb(3)-/Gb(2)-derivatives conjugated with phosphatidyl residue as a novel class of Stx-neutralizing agent.
志贺毒素(Stx)通过与靶细胞表面的糖鞘脂(主要是三糖基神经酰胺(Gb(3)))结合发挥毒性作用。抑制毒素-受体结合是预防Stx介导疾病的一种有前景的治疗方法。在本研究中,我们合成了磷脂酰乙醇胺二棕榈酰-Gb(3)(Gb(3)-PEDP)和半乳糖二糖基(Gb(2))-PEDP的单价Stx配体,并在体外检测了它们对Stx-1和Stx-2的中和活性。Gb(3)-PEDP和Gb(2)-PEDP均强烈中和了Stx-1和Stx-2的细胞毒性。中和机制可能涉及脂质体的形成以及糖单元的聚集。我们提出与磷脂酰残基缀合的单价Gb(3)/Gb(2)衍生物作为一类新型的Stx中和剂。